- In 2021, Delic’s investments and acquisitions allowed for an annualized revenue run-rate of over $9MM
- Going into the new year, the company looks forward to opening additional ketamine infusion treatment clinics, growing them by 15 within the next 18 months
- Delic’s growth has been attributed to the strong demand for alternatives to current treatments for mental health conditions
- Its management is confident that the foundations laid down so far position Delic for growth and profitability in 2022 and beyond
2021 was an excellent year for Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), as indicated in the company’s recent update (https://ibn.fm/HokJs), marked by key acquisitions and furthering its goal of providing the highest standard of care to patients. According to the management team, these achievements position the company well for growth and profitability in 2022 and beyond.
In November 2021, Delic closed the acquisition of Ketamine Wellness Centers (“KWC”), an enterprise that operated 10 ketamine infusion treatment clinics across the United States (https://ibn.fm/K3Vug). The purchase brings the total number of operational Delic clinics to 12, making it the largest chain of wellness centers providing ketamine treatments in the United States. Delic is also confident that within the next 18 months, there will be 15 more clinics in operation, ultimately sealing its position as the undisputed leader in the segment.
“At Delic, we have built the most profitable model for scaling the best-in-class care directly to patients through the largest network of mental health clinics in the U.S.,” noted Matt Stang, the Co-founder and Chief Executive Officer (“CEO”) of Delic.
All acquisitions for the 2021 financial year were geared towards accelerating Delic’s growth trajectory and establishing its self-sustaining ecosystem of businesses that currently comprises Ketamine Infusion Centers (“KIC”), Delic Labs, KWC and a number of media properties. In total, these investments allowed for the company to realize an annualized revenue run-rate of over $9MM, a figure which the company is confident will be surpassed in 2022.
Matt Stang, the Co-founder and Chief Executive Officer of Delic, has been keen to note that the company’s success has been primarily driven by the growing demand for alternatives to mainstream treatments for mental health conditions influenced by the ongoing pandemic.
“We are seeing a strong demand for alternatives to current treatments with lasting outcomes and less side effects,” Mr. Stang noted.
Delic’s media properties, including Meet Delic, arguably the world’s largest annual psychedelic wellness event, also demonstrate the power of the Delic ecosystem of businesses. In November 2021, it attracted over 2,500 attendees and over 2,000 inbound calls to clinics in a span of two days.
Through achievements such as these, coupled with the company’s aggressive expansion and rollout, Delic is differentiating itself, with management confident in growth and profitability in 2022 and beyond.
For more information, visit the company’s website at www.DelicCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.